Arcadia Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Arcadia Biosciences

17/05/2021 23:29

* Arcadia Biosciences Inc  RKDA.OQ  reported quarterly adjusted
earnings of 12 cents​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was for a
loss of 34 cents per share.
* Revenue rose 168% to $828.00 thousand from a year ago; 
analysts expected $736.67 thousand. 
* Arcadia Biosciences Inc's reported EPS for the quarter was 11
cents​.
* The mean earnings estimate of analysts had fallen by
about 16.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Arcadia Biosciences Inc shares had fallen by 10.0% this
quarter and lost 2.0% so far this year.
* The company reported quarterly net income of $2.06 million.
* Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 17 at 10:29 p.m. GMT.
​All figures in US dollars